NCT01403610 2019-07-24Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following BevacizumabThe University of Texas Health Science Center at San AntonioPhase 2 Completed28 enrolled 9 charts